Investment
Features
FeesSafety
Academy
More
Pluang+

HCA Healthcare faces securities fraud probe after cutting 2026 profit forecast, stock drops 7%.

Market News
10 Sep 2026
PRNewsWire
View Source
Bearish
HCA Healthcare faces securities fraud probe after cutting 2026 profit forecast, stock drops 7%.

HCA Healthcare sharply lowered its full-year 2026 profit guidance due to an unfavorable change in payer mix that reduced revenue by about $400 million in Q2. Following this announcement, HCA's stock price fell nearly 7%. Pomerantz LLP is investigating whether HCA and some of its executives engaged in securities fraud or other unlawful practices. Investors affected by this are encouraged to contact the law firm as a class action may be pursued.

More News (HCA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App